Gina Wang, MD
Cardiology · New York, NYNPI 1629091426
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 47.9% of the total. Reporting peaked in 2019 at $843 and has fallen 65.1% since, to $294 in 2025.
Across 261 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- AbbVie$2K
- Madrigal Pharmaceuticals$188
- Phathom Pharmaceuticals, Inc.$125
- Gilead$57
- Exact Sciences$53
- plus $185 from 8 others
What the payments were for
- Food & beverage$4,094100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 185 | $1,962 |
| AbbVie | 52 | $1,524 |
| Madrigal Pharmaceuticals | 9 | $188 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Gilead | 3 | $57 |
| Exact Sciences | 2 | $53 |
| Ironwood Pharmaceuticals, Inc | 2 | $45 |
| Astellas Pharma US Inc | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| Ardelyx, Inc. | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $12 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,094 in reported general payments places this provider in the 75th percentile of 112 cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $27,863 |
| Metoprolol Succinate | 45 | $810 |
| Amlodipine Besylate | 89 | $725 |
| Atorvastatin Calcium | 51 | $649 |
| Rosuvastatin Calcium | 36 | $584 |
| Pravastatin Sodium | 14 | $425 |
| Losartan Potassium | 33 | $416 |
| Simvastatin | 31 | $282 |
| Lisinopril | 13 | $215 |
| Metformin Hcl | 23 | $144 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 12 | $122 |
| Famotidine | 13 | $106 |
| Zolpidem Tartrate | 16 | $55 |
| Hydrochlorothiazide | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other cardiology in New York
- Michael SiegalNew York$43K
- Lori Vales LayNew York$9K
- David LefkowitzNew York$4K
- Jossef AmirianNew York$3K
- Philip VarrialeNew York$2K
- Luis AybarNew York$2K
- Haleh MilaniNew York$1K
- Eugene RhimNew York$1K
- Yaacov WeissNew York$1K
- Hassan BeydounNew York$594
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.